ABSTRACT
This study purported to determine the effect of pretreatment counseling upon discontinuation of 150 mg depot-medroxyprogesterone acetate (Depo-Provera) given for contraception. A total of 350 Mexican women participated: 175 received detailed structured pretreatment counseling about the hormonal effects of the injectable vs. routine counseling upon duration of use and efficacy of the method. Study termination rates were significantly lower in the structured counseling group than in the control group. Cumulative life table discontinuation rates were 17% (30/175) and 43.4% (76/175), respectively (p <0.05). The most common reasons for terminating DMPA were menstrual changes (8.6 and 32% for counseling and control group, respectively). The findings suggest that pretreatment counseling on expected side effects increases the continuation rates of DMPA users.
Subject(s)
Contraceptive Agents, Female/administration & dosage , Counseling , Medroxyprogesterone Acetate/administration & dosage , Patient Compliance , Adult , Amenorrhea/chemically induced , Contraceptive Agents, Female/adverse effects , Female , Humans , Medroxyprogesterone Acetate/adverse effects , Menstruation Disturbances/chemically induced , Mexico , Patient Dropouts , Patient Education as TopicABSTRACT
OBJECTIVE: To determine the symptoms of climacterium in women from rural areas of Yucatan. MATERIAL AND METHODS: We conducted a transversal study of 202 women in the villages of Seye and Cuzama. A questionnaire on socioeconomic status, and symptoms of the menopause was applied. RESULTS: In both villages, the commonest menopause-related symptoms were backache tiredness in more than half of the women. Sweating and hot flashes were reported by 35% and 31%, respectively. CONCLUSION: Our observations differed from the absence of hot flashes and sweating reported by another group in rural women living in Yucatan (Ref 7).
Subject(s)
Climacteric , Adult , Female , Humans , Mexico , Middle Aged , Rural PopulationABSTRACT
Menopause is the physiologic state that is a consequence of the cessation of ovarian function. A large number of vasomotor, psychological and gynecological symptoms have been associated with menopause. Hormonal replacement therapy is effective in treating these conditions. The use of estrogens and progestins including dosages, routes of administration and their advantages and disadvantages are reviewed in this article. In addition, hormonal replacement therapy may reduce the risk of atherosclerosis and prevent the osteoporosis of climateric women. Hormonal therapy is associated with side effects but they do not contraindicate its use.
